Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers

NCT02992236 is registered in ClinicalTrials.gov with veriNOS operations GmbH as lead sponsor.

NCT NCT02992236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02992236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers
Lead sponsor
veriNOS operations GmbH
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2015
Completion date
November 30, 2016
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal function impairment in healthy volunteers